Targeting Immunological Restrainers Understanding the Immunology Behind Combination Chemo Immunotherapy to Improve the Treatment of Malignant Mesothelioma

Project Details

StatusFinished
Effective start/end date30/09/1229/09/14

Funding

  • Department of Defense (United States): A$1,419,717.00